Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-human epidermal growth factor receptor 2 monoclonal antibody combined with nanomicelle and its preparation and application

A technology of epidermal growth factor and monoclonal antibody, which is applied in the field of biomedicine, can solve the problems of side effects, inability to distinguish cancer cells from normal cells, and toxicity, and achieve the effects of small side effects, superior anti-tumor activity, and reduced side effects

Active Publication Date: 2018-10-19
上海蓝西实验设备有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most clinical anticancer agents still cannot distinguish cancer cells from normal cells, resulting in systemic toxicity and serious side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human epidermal growth factor receptor 2 monoclonal antibody combined with nanomicelle and its preparation and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] 1. Structural modification of polyoxyethylene-polyoxypropylene-polyoxyethylene block polymers

[0031] a) Synthesis and characterization of carboxylated block polymer P123 (CT-P123);

[0032] The specific steps of polymer surface modification are: under the action of sodium hydroxide, the addition reaction of 2-butenenitrile and polyoxyethylene-polyoxypropylene-polyoxyethylene block polymer occurs, and then the addition reaction is carried out by stirring reaction The nitrile group contained in the product is hydrolyzed, and xylene is used to extract from the hydrolysis reaction product liquid to obtain a carboxyl PEO-PPO-PEO block copolymer product.

[0033] b) Linkage of CT-P123 and anti-HER2 monoclonal antibody:

[0034] The specific steps of linking the polymer molecule to the monoclonal antibody are as follows: the carboxyl activator 1-ethyl-(3-dimethylaminopropyl) carbodiimide (EDC) and polyoxyethylene-polyoxypropylene-polyoxygen Ethylene block polymer modificat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a combined nano-micelle of monoclonal antibodies for resisting human epidermal receptors 2 and preparation and application of the combined nano-micelle. The nano-micelle is formed by connecting monoclonal antibodies for resisting human epidermal receptors 2 with carbonylation polyoxyethylene-polyoxypropylene-polyoxyethylene block polymers. The invention further discloses the immune micelle prepared by wrapping the monoclonal antibodies for resisting human epidermal receptors 2 as medicine carriers on taxol, and preparation and application of the immune micelle. By means of the immune micelle, medicine can be sent to a certain target position, the anti-tumor effects of taxol and antibodies for resisting human epidermal receptors 2 (HER2) are achieved, tumor cells are dead, and the acting time of medicine on a tumor part is prolonged; better anti-tumor activity and smaller toxic and side effects are achieved.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to anti-human epidermal growth factor receptor 2 monoclonal antibody combined with nano micelles and its preparation and application. Background technique [0002] Breast cancer is a common malignant tumor occurring in the breast ductal epithelium in women. The incidence rate is (11-80) / 100,000, and the case fatality rate is (0.7-26.6) / 100,000, accounting for 7%-10% of various malignant tumors in the whole body. Breast cancer occurs all over the world, and has the highest incidence among gynecological tumors in many western countries. Breast cancer has seriously jeopardized the physical and mental health of Chinese women, and its incidence rate has shown an obvious upward trend in the past 20 years. It has occupied the top two tumor incidence rates among women in large cities in China. [0003] At present, the treatment of breast cancer mainly adopts surgery, supplemented by radiotherap...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/51A61K47/42A61K31/337A61P35/00
Inventor 倪健
Owner 上海蓝西实验设备有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com